81 related articles for article (PubMed ID: 4150008)
1. [Dose-response relationship of beta-adrenergic blocking agents].
Seyberth H
Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1663-5. PubMed ID: 4150008
[No Abstract] [Full Text] [Related]
2. Protection against isoprenaline induced myocardial necroses by beta-adrenergic blocking agents.
Kulig A; Kostka-Trabka E; Gryglewski R
Pol J Pharmacol Pharm; 1973; 25(1):85-90. PubMed ID: 4149575
[No Abstract] [Full Text] [Related]
3. Isoproterenol blockade in man; comparison between penbutalol and acebutolol.
Coleman AJ; Leary WP; Asmal AC
Curr Ther Res Clin Exp; 1974 Jan; 16(1):64-79. PubMed ID: 4149207
[No Abstract] [Full Text] [Related]
4. Nitrilophenoxypropanolamines: influence of ring substitution on beta-receptor blockade.
Mylecharane EJ; Raper C
Eur J Pharmacol; 1974 Nov; 29(1):93-101. PubMed ID: 4154862
[No Abstract] [Full Text] [Related]
5. [Hemodynamic action of talinolol (Cordanum, 02-115), a new beta-receptor blocking substance, in man].
Wolf P; Feller K; Femmer K
Pharmazie; 1975 Oct; 30(10):678-81. PubMed ID: 696
[No Abstract] [Full Text] [Related]
6. [Inotropic effects of several adrenergic beta blockers in a dog subjected to electrosystolic cardiac impulse].
Cheymol G; Mouillé P; Schmitt H; Laubie M
Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):45-51. PubMed ID: 4148408
[No Abstract] [Full Text] [Related]
7. The selective beta receptor blocking properties of DL-1-(2-acetyl-4-n-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane HC1 (M & B 17803-A) in the anesthetized dog.
Levy B
J Pharmacol Exp Ther; 1973 Jul; 186(1):134-44. PubMed ID: 4146701
[No Abstract] [Full Text] [Related]
8. [Studies on the action of talinolol (Cordanum, 02-115) on the coronary blood circulation].
Modersohn D; Femmer K
Pharmazie; 1975 Oct; 30(10):652-5. PubMed ID: 689
[No Abstract] [Full Text] [Related]
9. [Action of various beta adrenolytic agents on the alpha blocking properties of yohimbine in the dog].
Mouillé P; Cheymol G
C R Seances Soc Biol Fil; 1973; 167(3):440-2. PubMed ID: 4150410
[No Abstract] [Full Text] [Related]
10. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
Horii D; Kawada T; Takeda K; Imai S
Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
[No Abstract] [Full Text] [Related]
11. [Atypical dose-frequency relation as characteristic of a beta receptor blocker].
Klempt HW; Müller WD; Bender F
Verh Dtsch Ges Inn Med; 1973; 79():1015-8. PubMed ID: 4151337
[No Abstract] [Full Text] [Related]
12. Effects of prolonged treatment with adrenergic beta-receptor antagonists on blood pressure, cardiovascular design and reactivity in spontaneously hypertensive rats (SHR).
Weiss L; Lundgren Y; Folkow B
Acta Physiol Scand; 1974 Aug; 91(4):447-57. PubMed ID: 4154700
[No Abstract] [Full Text] [Related]
13. Cardiovascular effects of tolamolol (UK-6558), a new beta-adrenoreceptor blocking drug, in pinealectomized hypertensive rats.
Karppanen H; Lahovaara S; Mattila MJ
Ann Med Exp Biol Fenn; 1973 Mar; 51(3):104-11. PubMed ID: 4149365
[No Abstract] [Full Text] [Related]
14. Effects of propranolol and a new 'cardioselective' beta-blocker, H 93-26, on responses of isolated rat atria to isoprenaline and noradrenaline.
Johansson B
Eur J Pharmacol; 1973 Nov; 24(2):194-204. PubMed ID: 4148794
[No Abstract] [Full Text] [Related]
15. Central actions of some beta-adrenoceptor blocking agents.
Shah UH; Jindal MN; Patel VK; Kelkar VV
Arzneimittelforschung; 1974 Oct; 24(10):1581-4. PubMed ID: 4154760
[No Abstract] [Full Text] [Related]
16. Beta receptor blocking and antiarrhythmic properties of tolamolol.
Bagwell EE; Custy J; Steen RG; Newman WH
J Pharmacol Exp Ther; 1974 Dec; 191(3):496-505. PubMed ID: 4154378
[No Abstract] [Full Text] [Related]
17. Relative beta adrenergic receptor blocking activity in dogs after intravenous and intraportal vein administration: bunolol, propranolol, their levo isomers and sotalol.
Kaplan HR; Commarato MA
J Pharmacol Exp Ther; 1973 May; 185(2):395-405. PubMed ID: 4145046
[No Abstract] [Full Text] [Related]
18. Evaluation of beta-adrenolytic properties of N,N'-bis-(3-(p-methoxyphenoxy)-2-hydroxypropyl)-ethylenediamine and its N,N'-dimethyl derivative.
Robak J; Grodzińska L
Pol J Pharmacol Pharm; 1973; 25(3):253-7. PubMed ID: 4150018
[No Abstract] [Full Text] [Related]
19. Cardiovascular beta-adrenergic receptor blocking activities of 1-(7-indenyloxy)-3-isopropyl-aminopropane-2-ol hydrochloride (YB-2) and its optical isomers.
Kato H; Noguchi Y; Nakao K; Takagi K
Jpn J Pharmacol; 1974 Apr; 24(2):261-70. PubMed ID: 4152803
[No Abstract] [Full Text] [Related]
20. Beta-blocking drug metipranolol: plasma levels and pharmacodynamic action in man.
Mayer O; Cepelák V; Vitous J; Potmĕsil J
Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):113-9. PubMed ID: 6103879
[No Abstract] [Full Text] [Related]
[Next] [New Search]
